Obesity and being overweight are common problems among people taking antipsychotic medications. Studies indicate that between 40 and 80 percent of individuals taking second-generation antipsychotics gain up to 20 percent of their ideal body weight. This weight gain is often influenced by factors such as motivation and energy problems that reduce the capacity for healthy nutrition and regular exercise.
Obesity is a major health concern, and motivating someone to participate in an exercise program that he or she is not ready for is a major challenge for health practitioners.
The goal of this study, conducted by a team of researchers from McMaster University and St. Joseph's Healthcare in Hamilton led by Suzanne Archie, MD, was to use the transtheoretical model to determine the diet and physical activity patterns of people with psychotic disorders and identify which of these individuals were ready to consider lifestyle changes that would help them manage their weight. The transtheoretical model, also know as the "stages of change" model, identifies six stages of change and is designed to help health practitioners assess how ready patients are to change their lifestyles.
In this case, researchers based their study on the PatientCentered Assessment for Exercise and Nutrition questionnaire, which condenses the six transtheoretical model stages into three: precontemplation, contemplation-preparation and action. The objective was to identify people in the contemplation-preparation range-the stage that indicates a readiness for change.
The study surveyed a total of 101 participants between the ages of 18 and 55 diagnosed with a psychiatric disorder, of which 71 percent had schizophrenia or schizoaffective disorder. Of the 99 participants for whom a Body Mass Index (BMI) score was calculated, only 24 percent had scores within the normal range, compared to 46.7 percent for Canadians overall. Among study participants, 38 percent of the sample were overweight (compared with 33.3 percent of Canadians), while 36 percent were obese (compared to 14 percent of Canadians).
Among the study's findings:
• On average, participants in the study exercised for 30 minutes, 1.4 to 1.9 times per week, compared to the British Heart Foundation's recommendation of 30 minutes of vigorous exercise five times per week; • In general, study participants consumed vegetables and fiber infrequently-8 percent ate vegetables once a day, 17 percent consumed fruit at least twice a day, and 38 percent ate a green salad once a week-and consumed fat at a level just below what is considered "unacceptable" by nutritionists. When it came to the participants' readiness to change their lifestyles:
• People who were obese were not ready to improve their eating habits, while overweight people were ready to change; • People who were in the contemplation-preparation stage for changing their eating habits were also in the same stage for increasing their physical activity; • 50 percent of participants were in the contemplationpreparation stage for either eating habits or physical activity, while 10 percent were in the pre-contemplation stage.
The finding that 50 percent of participants were in the contemplation-preparation stage is encouraging given that previous studies of people with schizophrenia found lower proportions in this stage. It also suggests that promoting lifestyle changes may be a viable approach for people with mental illness. This could include educating people to make better food choices and encouraging them to participate in exercise such as walking, jogging and cycling, options that are both inexpensive and accessible to many people.
The study also recommends tailoring lifestyle counselling to an individual's readiness for change. For example, those in the precontemplation stage could be encouraged to identify potential benefits, drawbacks, and roadblocks to healthy eating, while those in the contemplation-preparation group could move on to weighing the benefits and costs of healthy lifestyle activities.
The full study can be found in the journal Psychiatric Services, volume 58 no. 2, published in 2007 (pages 233-9).
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Welcome to Making Research Real, the Schizophrenia Society of Ontario's forum for current developments in schizophrenia research from across Canada. Making Research Real is designed to provide information that is current, applicable, and relevant to showcase ground-breaking work that can make a difference in the lives of those living with schizophrenia. Many studies have examined the inner workings of the schizophrenic brain. Typically, the brains of people with schizophrenia exhibit a variety of difficulties in processing information. In this study, researchers wanted to test the hypothesis that schizophrenia is associated with impaired activity in the delta and theta brain waves. Delta and theta waves are types of relatively low-frequency brain waves, and while a number of studies have looked at spontaneous activity in this wave range, few have examined what happens when subjects are asked to perform specific tasks.
The study, conducted by a team of researchers including Alan Bates from the University of British Columbia, examined delta and theta wave activity associated with information processing in 17 people with schizophrenia and 17 controls.
Study participants were required to complete two oddball target detection tasks, in which they had to identify a particular image that only appeared occasionally within a series of standard images. In the first task, participants were to respond with their right index finger each time a white X appeared on a computer monitor and not to respond when they saw a white O. The second task had them respond with their right index finger every time a white X appeared and not to respond to a white K. Researchers recorded the participants' reaction times and the number of correct and incorrect responses for each task, while electrodes spread over the participants' scalps recorded brain activity while the tasks were being performed.
On both tasks, participants from the control group-people who did not have schizophrenia-responded significantly faster on correct answers than those with schizophrenia. Also, on the task asking participants to respond to the letter X and not the letter K, those from the control group had more correct responses than the people with schizophrenia.
Results of brain activity recorded during the tasks revealed that the participants with schizophrenia also exhibited significantly less activity in both delta and theta bands related to the task they were asked to perform.
These findings suggest that delta and theta brain waves are not coordinated effectively during various information processing tasks among people with schizophrenia. This study also appears to support the findings of previous studies that problems with attention among people with schizophrenia may be related to reduced theta wave activity.
The full study can be found in the journal Schizophrenia Research, volume 115, published in 2009 (pages 222-30 Little is known about how dosage levels of antipsychotic medications should be adjusted based on a person's age. While treatment guidelines recommend that older people with schizophrenia receive half the regular adult dose, it's not clear if health practitioners consistently follow these guidelines. Because many health practitioners stick to the formula that "the dose that gets you well, keeps you well, " medication dosages are often not adjusted for age.
What have they found?
The researchers' goal was to review existing literature about the effects of age on antipsychotic dosing, and to look for causes of the sensitivity to antipsychotics that develops with age. What they found was that in general, dosages increased with age during the first three decades of a patient's life, reached a plateau, and then decreased after the fifth decade. The likely explanation for the increasing dose in a patient's early years is the deterioration process that goes along with the early phase of schizophrenia, while the declining dose in a patient's later years is likely associated with physical aging. The research also found that the increased sensitivity to antipsychotics that comes with age is likely due to age-related decline in the dopaminergic system-a system of nerve cells that uses dopamine to transmit impulses between nerves.
Why does it matter?
The issue behind this research is concern about the safety and level of tolerance of antipsychotics among the elderly. If we can better understand normal age-related changes in people with schizophrenia, this should allow for more individualized treatment and help health practitioners work towards finding the lowest possible effective dose as patients age, thus minimizing medication side effects.
The full study is available in the journal Progress in Neuropsychopharmacology & Biological Psychiatry, volume 33 number 6, published in 2009 (pages 917-20) .
